{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:42:30Z","timestamp":1784133750592,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.bcp.2005.09.026","type":"journal-article","created":{"date-parts":[[2005,11,17]],"date-time":"2005-11-17T12:16:37Z","timestamp":1132229797000},"page":"1870-1882","source":"Crossref","is-referenced-by-count":19,"title":["Kinetics of tienilic acid bioactivation and functional generation of drug\u2013protein adducts in intact rat hepatocytes"],"prefix":"10.1016","volume":"70","author":[{"given":"M. Pilar","family":"L\u00f3pez-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Dansette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Coloma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2005.09.026_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-2008-1040486","article-title":"Drug-induced allergic hepatitis","volume":"10","author":"Pohl","year":"1990","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bcp.2005.09.026_bib2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF03189993","article-title":"Drug-induced inmmunotoxicity","volume":"23","author":"Dansette","year":"1998","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.bcp.2005.09.026_bib3","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2165\/00002018-200023060-00002","article-title":"Immunological principles of adverse drug reactions: the initiation and propagation of immune response elicited by drug treatment","volume":"23","author":"Naisbitt","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.bcp.2005.09.026_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0009-2797(02)00051-0","article-title":"A review of the common properties of drugs with idiosyncratic hepatotoxicity and the \u201cmultiple determinant hypothesis\u201d for the manifestation of idiosyncratic drug toxicity","volume":"142","author":"Li","year":"2002","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bcp.2005.09.026_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tox.2004.12.019","article-title":"Role of drug metabolism for breaking tolerance and the localization of drug hypersensitivity","volume":"209","author":"Uetrecht","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2005.09.026_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrd1605","article-title":"Genetic aspects of immune-mediated adverse drug effects","volume":"4","author":"Bugelski","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bcp.2005.09.026_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0167-5699(98)80012-1","article-title":"Allergic and autoimmune reactions to xenobiotics: how do they arise?","volume":"19","author":"Griem","year":"1998","journal-title":"Immunol Today"},{"key":"10.1016\/j.bcp.2005.09.026_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0300-483X(02)00255-X","article-title":"The danger hypothesis: potential role in idiosyncratic drug reactions","volume":"181\/182","author":"Pirmohamed","year":"2000","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2005.09.026_bib9","first-page":"561","article-title":"A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis","volume":"55","author":"Homberg","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bcp.2005.09.026_bib10","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/0006-2952(84)90409-X","article-title":"Metabolic hydroxylation of the thiophene ring: isolation of 5-hydroxy-tienilic acid as the major urinary metabolite of tienilic acid in man and rat","volume":"33","author":"Mansuy","year":"1984","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2005.09.026_bib11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0006-2952(90)90207-2","article-title":"Oxidative activation of the thiophene ring by hepatic enzymes. Hydroxylation and formation of electrophilic metabolites during metabolism of tienilic acid and its isomer by rat liver microsomes","volume":"39","author":"Dansette","year":"1990","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2005.09.026_bib12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0006-2952(91)90627-H","article-title":"Hydroxylation and formation of electrophilic metabolites of tienilic acid and its isomer by human liver microsomes. Catalysis by cytochrome P450 IIC different from that responsible for mephenytoin hydroxylation","volume":"41","author":"Dansette","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2005.09.026_bib13","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1021\/ja00020a089","article-title":"Thiophene S-oxides as new reactive metabolites: formation by cytochrome P450 dependent oxidation and reaction with nucleophiles","volume":"113","author":"Mansuy","year":"1991","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bcp.2005.09.026_bib14","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1021\/bi9823030","article-title":"Electrospray ionization mass spectrometric analysis of intact cytochrome P450: identification of tienilic acids adducts to P450 2C9","volume":"38","author":"Koenigs","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2005.09.026_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-1-4615-0667-6_17","article-title":"Use of isotopes and LC-MS-ESI-TOF for mechanistic studies of tienilic acid metabolic activation","volume":"500","author":"Belghazi","year":"2001","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.bcp.2005.09.026_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1021\/bi00167a022","article-title":"Thiophene derivatives as a new mechanism-based inhibitors of cytochromes P-450: inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acid","volume":"33","author":"L\u00f3pez-Garc\u00eda","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2005.09.026_bib17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1021\/tx980136z","article-title":"Opposite behaviors of reactive metabolites of tienilic acid and its isomer toward liver proteins: use of specific anti-tienilic acid-protein adduct antibodies and the possible relationship with different hepatotoxic effects of the two compounds","volume":"12","author":"Bonierbale","year":"1999","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.bcp.2005.09.026_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1432-1033.1993.tb17752.x","article-title":"Human-liver cytochrome P-450 expressed in yeast as tools for reactive-metabolite formation studies","volume":"213","author":"L\u00f3pez-Garc\u00eda","year":"1993","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bcp.2005.09.026_bib19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1432-1033.1996.00797.x","article-title":"Oxidation of tienilic acid by human yeast-expressed cytochrome P-450 2C8, 2C9, 2C18 and 2C19. Evidence that this drug is a mechanism-based inhibitor specific for cytochrome P-450 2C9","volume":"241","author":"Jean","year":"1996","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bcp.2005.09.026_bib20","first-page":"1328","article-title":"Detection of human hepatitis anti-liver kidney microsomes (LKM2) autoantibodies on rat liver sections is predominantly due to reactivity with rat liver P450 2C11","volume":"259","author":"Pons","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2005.09.026_bib21","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1172\/JCI118936","article-title":"Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera","volume":"98","author":"Robin","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2005.09.026_bib22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1021\/tx00039a023","article-title":"Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs","volume":"7","author":"Lecoeur","year":"1994","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.bcp.2005.09.026_bib23","first-page":"326","article-title":"Tienilic acid-induced autoimmune hepatitis: anti-liver and -kidney microsomal type 2 autoantibodies recognize a three-site conformational epitope on cytochrome P4502C9","volume":"50","author":"Lecoeur","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2005.09.026_bib24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0076-6879(96)72010-4","article-title":"Use of heterologous expression systems to study autoimmune drug-induced hepatitis","volume":"272","author":"Lecoeur","year":"1996","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.bcp.2005.09.026_bib25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00008571-200008000-00004","article-title":"Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis","volume":"10","author":"Aithal","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bcp.2005.09.026_bib26","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/00008571-200011000-00005","article-title":"Association analysis of drug metabolizing enzyme gene polymorphism in HIV-positive patients with co-trimoxazole hypersensitivity","volume":"10","author":"Pirmohamed","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bcp.2005.09.026_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clpt.2004.08.009","article-title":"Clinical consequences of cytochrome P450 2C9 polymorphisms","volume":"77","author":"Kirchheiner","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bcp.2005.09.026_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1054-3589(08)60175-1","article-title":"Autoantibodies against cytochrome P450: role in human diseases","volume":"30","author":"Beaune","year":"1994","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.bcp.2005.09.026_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-5793(98)01283-6","article-title":"Endogenous nitric oxide is responsible for the early loss of P450 in cultured rat hepatocytes","volume":"438","author":"L\u00f3pez-Garc\u00eda","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2005.09.026_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-5793(00)02388-7","article-title":"Differential sensitivity of rat hepatocyte CYP isoforms to self-generated nitric oxide","volume":"488","author":"Vernia","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2005.09.026_bib31","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/0006-2952(90)90290-2","article-title":"Hydroxylation of the thiophene ring by hepatic monooxigenases. Evidence for 5-hydroxylation of the 2-aroylthiophenes as a general metabolic pathway using a simple UV\u2013visible assay","volume":"39","author":"Neau","year":"1990","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2005.09.026_bib32","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0076-6879(78)52024-7","article-title":"The measurement of difference spectra: application to the cytochromes of microsomes","volume":"32","author":"Estbrook","year":"1978","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.bcp.2005.09.026_bib33","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0003-2697(76)90326-2","article-title":"A fluorometric method for determination of oxidized and reduced glutathione in tissues","volume":"74","author":"Hissin","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bcp.2005.09.026_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2005.09.026_bib35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0014-5793(99)01789-5","article-title":"Peroxynitrite generated from constitutive nitric oxide synthase mediates the early biochemical injury in short-term cultured hepatocytes","volume":"466","author":"L\u00f3pez-Garc\u00eda","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2005.09.026_bib36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0887-2333(03)00146-2","article-title":"Activation of signalling pathways during hepatocyte isolation: relevance to toxicology in vitro","volume":"18","author":"Paine","year":"2004","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.bcp.2005.09.026_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF03189454","article-title":"Metabolism of tienilic acid (ticrynafen) in man. Pharmacokinetic and mass spectrometric studies","volume":"5","author":"Vinay","year":"1980","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.bcp.2005.09.026_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1124\/dmd.33.1.115","article-title":"Prediction of in vitro intrinsic clearance from hepatocytes; comparison of suspensions and monolayer cultures","volume":"33","author":"Griffin","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2005.09.026_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF03189295","article-title":"Pharmacokinetic study of 2, 3-dichloro 4-(2-Thienyl keto 14C) Phenoxyacetic acid (tienilic acid) in animals","volume":"3","author":"Levron","year":"1977","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.bcp.2005.09.026_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cbi.2004.09.001","article-title":"Animal models of idiosyncratic drug reactions","volume":"150","author":"Shenton","year":"2004","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bcp.2005.09.026_bib41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.yexmp.2004.10.004","article-title":"A new model of drug hapten-induced hepatitis with increase mast cells in the BALB\/c mouse","volume":"78","author":"Njoku","year":"2005","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.bcp.2005.09.026_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tox.2004.12.017","article-title":"Tolerogenic role of Kupffer cells in immune-mediated adverse drug reactions","volume":"209","author":"Ju","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2005.09.026_bib43","doi-asserted-by":"crossref","first-page":"17940","DOI":"10.1074\/jbc.273.28.17940","article-title":"Identification of the hepatic protein targets of reactive metabolites of acetaminophen in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry","volume":"273","author":"Qiu","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2005.09.026_bib44","first-page":"936","article-title":"Processing of endoplasmic reticulum luminal antigens associated with halothane hepatitits in rat hepatocytes","volume":"22","author":"Amouzadeh","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2005.09.026_bib45","first-page":"237","article-title":"Selective protein adducts to membrane proteins in cultured rat hepatocytes exposed to diclofenac. Radiochemical and immunological analysis","volume":"45","author":"Kretz-Rommel","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2005.09.026_bib46","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/tx960167z","article-title":"Cytochrome P4502C11 is a target of diclofenac covalent binding in rats","volume":"10","author":"Shen","year":"1997","journal-title":"Chem Res Toxicol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295205006325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295205006325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:16:57Z","timestamp":1626740217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295205006325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0006295205006325"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2005.09.026","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}